Published in Antimicrob Agents Chemother on July 01, 2001
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother (2003) 3.76
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 1.75
Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model. Antimicrob Agents Chemother (2002) 1.03
Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother (2006) 0.92
Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model. Antimicrob Agents Chemother (2003) 0.90
Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.86
The Advantage of Bactericidal Drugs in the Treatment of Infection. Curr Infect Dis Rep (2004) 0.85
Pharmacodynamics of moxifloxacin and levofloxacin at simulated epithelial lining fluid drug concentrations against Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 0.83
Pharmacokinetics of gatifloxacin in infants and children. Antimicrob Agents Chemother (2005) 0.83
Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum. Antimicrob Agents Chemother (2003) 0.82
Vitreous penetration of orally administered gatifloxacin in humans. Trans Am Ophthalmol Soc (2002) 0.75
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother (1993) 7.05
In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother (1998) 4.88
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother (1993) 4.76
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob Agents Chemother (1996) 2.20
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother (1998) 2.19
Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agents Chemother (1997) 2.09
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother (1999) 2.06
Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother (1999) 1.73
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (1999) 1.46
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations. Antimicrob Agents Chemother (2000) 1.33
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. Int J Antimicrob Agents (1999) 1.24
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol (2001) 6.21
Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst (2000) 4.51
Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci (1975) 4.01
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis (1982) 3.96
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial. Neurology (2002) 3.73
Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol (1998) 3.58
In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med (1994) 3.25
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science (2001) 3.22
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother (1997) 3.17
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol (2000) 2.67
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology (2006) 2.64
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother (1995) 2.49
Changing sexual attitudes and behaviour in China: implications for the spread of HIV and other sexually transmitted diseases. AIDS Care (1999) 2.35
Structures of two repeats of spectrin suggest models of flexibility. Cell (1999) 2.30
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology (2008) 2.29
Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology (2001) 2.23
A comparative linkage map of oilseed rape and its use for QTL analysis of seed oil and erucic acid content. Theor Appl Genet (2006) 2.21
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A (1998) 2.13
Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis (1991) 2.12
Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler (2012) 2.07
Airway mucosa: secretory cells, mucus and mucin genes. Eur Respir J (1997) 2.06
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother (1999) 2.06
3D magnetization-prepared true-FISP: a new technique for imaging coronary arteries. Magn Reson Med (2001) 2.00
Infection thread formation as a basis of nodulation specificity in Rhizobium--strawberry clover associations. Can J Microbiol (1969) 1.98
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. J Neurol Neurosurg Psychiatry (2010) 1.94
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Injecting drug use and HIV infection in southwest China. AIDS (1994) 1.91
Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91
Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A (1997) 1.88
Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87
Surface signaling in pathogenesis. Proc Natl Acad Sci U S A (1995) 1.81
Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience (2007) 1.80
Positron emission tomography in manganese intoxication. Ann Neurol (1989) 1.78
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol (1988) 1.76
Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol (1999) 1.74
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem (2001) 1.73
Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev (1999) 1.73
P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res (1993) 1.72
Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis (2001) 1.72
Retracted Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab. Br J Cancer (2010) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother (1996) 1.68
Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest (1999) 1.67
Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results. Magn Reson Med (1993) 1.65
The corpus callosum is larger with right-hemisphere cerebral speech dominance. Ann Neurol (1988) 1.64
Genetic diversity of hantaviruses isolated in china and characterization of novel hantaviruses isolated from Niviventer confucianus and Rattus rattus. Virology (2000) 1.64
An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia (2011) 1.61
Neuronal peptide release is limited by secretory granule mobility. Neuron (1997) 1.61
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res (2001) 1.60
Isolation and initial characterization of a newfound hantavirus from California. Virology (1995) 1.59
The Ty1-copia group retrotransposons in Vicia species: copy number, sequence heterogeneity and chromosomal localisation. Mol Gen Genet (1996) 1.59
Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. . Microb Drug Resist (2000) 1.57
Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. J Antimicrob Chemother (1989) 1.55
Parental warmth, control, and indulgence and their relations to adjustment in Chinese children: a longitudinal study. J Fam Psychol (2000) 1.55
Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am J Physiol (1999) 1.50
Human eHAND, but not dHAND, is down-regulated in cardiomyopathies. J Mol Cell Cardiol (2001) 1.50
Detection of B-mode polarization in the cosmic microwave background with data from the South Pole Telescope. Phys Rev Lett (2013) 1.48
How established wait time benchmarks significantly underestimate total wait times for cardiac surgery. Can J Cardiol (2010) 1.47
The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am (1977) 1.45
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. J Antimicrob Chemother (1985) 1.44
Absorption of vancomycin. Ann Intern Med (1984) 1.40
Chylous transport of amiodarone. Chest (1992) 1.40
Structure of complement receptor 2 in complex with its C3d ligand. Science (2001) 1.40
Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci (2000) 1.38
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J Pharm Sci (1986) 1.34
Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. J Virol (1999) 1.34
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations. Antimicrob Agents Chemother (2000) 1.33
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob Agents Chemother (1991) 1.33
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa. J Pharmacokinet Biopharm (1988) 1.32
Basic mechanisms of atrial fibrillation--very new insights into very old ideas. Annu Rev Physiol (2000) 1.31
Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci U S A (2005) 1.30
Accuracy of common hapatic duct size in the evaluation of extrahepatic biliary obstruction. Radiology (1980) 1.30
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J Virol (2000) 1.29
Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation (1999) 1.29
Immediate provisional for single-tooth implant replacement with Brånemark system: preliminary report. Clin Implant Dent Relat Res (2001) 1.27
Lesions of the putamen and dystonia: CT and magnetic resonance imaging. Neurology (1984) 1.26
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother (1997) 1.26
Myosin II distribution in neurons is consistent with a role in growth cone motility but not synaptic vesicle mobilization. Neuron (1992) 1.25
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother (1993) 1.25
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. Int J Antimicrob Agents (1999) 1.24
Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene (1995) 1.24
Effect of protein binding on drug penetration into blister fluid. Antimicrob Agents Chemother (1988) 1.22
Distinct structural requirements for clustering and immobilization of K+ channels by PSD-95. J Gen Physiol (1999) 1.21
Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus. Avian Pathol (1992) 1.21
Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res (1997) 1.20
The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest (1996) 1.19